Background Polypharmacy is a common global health concern in the older population. Deprescribing has been acknowledged as an important aspect of medication use review that helps to reduce polypharmacy, inappropriate medication uses and medication ...
Wuraola Akande-Sholabi +2 more
doaj +5 more sources
Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review [PDF]
Objective To synthesise the current knowledge on barriers and facilitators to deprescribing cardiovascular medications (CVMs) at the levels of patients, informal caregivers and healthcare providers (HCPs).Design/setting We conducted a systematic review ...
Nicolas Rodondi +2 more
doaj +3 more sources
A Cross-Sectional Analysis of Deprescribing Curricular Exposure, Attitudes, and Preparedness Among Undergraduate Pharmacy Students in Saudi Arabia [PDF]
Objectives: This study aimed to assess pharmacy students’ curricular exposure to deprescribing, their attitudes and preparedness to perform core deprescribing steps, and their understanding of interprofessional roles in the deprescribing process. Methods:
Lina Altayeb +5 more
doaj +2 more sources
Pharmacotherapy and Deprescribing
This chapter discusses the concept and practice of deprescribing. Deprescribing has been defined as the process of identifying and withdrawing an inappropriate medication, supervised by a health-care professional. Evidence on the outcomes of deprescribing (benefits and safety) is presented followed by a discussion of the barriers to, enablers of and ...
Reeve, Emily +2 more
openaire +5 more sources
Deprescribing proton pump inhibitors in long-term care: Outcomes of a pharmacist-led initiative [PDF]
Background: Proton pump inhibitors (PPIs) are frequently continued without clear indication in long-term care (LTC) settings. Evidence-based deprescribing strategies may reduce unnecessary exposure, but real-world data from Middle Eastern LTC facilities ...
Amira Muhana +5 more
doaj +2 more sources
Deprescribing in advanced illness [PDF]
© 2016 Informa UK Limited, trading as Taylor & Francis Group. Patients with advanced illness such as cancer, chronic obstructive pulmonary disease, and Parkinson's disease experience acute symptoms and are usually prescribed medications to manage these, alongside drugs to treat other co-morbid, long-term conditions. As such, the pharmacotherapeutic
Olusola Akinbolade +3 more
openaire +4 more sources
Artificial intelligence tool utilization in deprescribing practices among community pharmacists in Jordan: a cross-sectional study [PDF]
IntroductionData on artificial intelligence-supported deprescribing in Jordanian community pharmacy are still lacking. This study aimed to assess current deprescribing practices among community pharmacists in Jordan, identify the medication classes most ...
Ahmad Z. Al Meslamani +4 more
doaj +2 more sources
Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes [PDF]
The English National Overprescribing Review identified that older people often take eight or more medicines a day. The report recommended pharmacists in primary care should take responsibility for addressing polypharmacy.
Jeanette Blacklock (11516339) +7 more
core +8 more sources
Deprescribing: An umbrella review
This umbrella review examined systematic reviews of deprescribing studies by characteristics of intervention, population, medicine, and setting. Clinical and humanistic outcomes, barriers and facilitators, and tools for deprescribing are presented.
Japelj Nuša +3 more
doaj +4 more sources
Deprescribing in migraine [PDF]
The Global Burden of Diseases study (GBD2019), recently published in Lancet, reported the global disability data, expressed as years lived with disability (YLDs), of great relevance for headache di...
Paolo Martelletti +3 more
openaire +3 more sources

